Biomedical Primate Research Centre
BPRC is a Dutch non-profit research foundation using non-human primate models and biobank resources to advance biomedical research on infectious diseases, neurodegenerative disorders, and vaccine development, serving the global scientific community, pharmaceutical companies, and the Dutch government.
- Company typePrivate
- Founded1997
- HeadquartersRijswijk, Netherlands
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Biomedical Primate Research Centre does
Biomedical Primate Research Centre (BPRC) is a Dutch non-profit research foundation (Stichting Biomedical Primate Research Centre) established in 1997 in Rijswijk, Netherlands, operating as the country's dedicated non-human primate (NHP) biomedical research facility. BPRC employs approximately 110–114 staff across 15 nationalities and maintains a breeding colony of ~900 rhesus macaques, marmosets, and long-tailed macaques. The organization conducts research into infectious diseases (HIV/AIDS, tuberculosis, malaria, COVID-19, influenza), neurodegenerative disorders (Parkinson's, Alzheimer's, Long COVID neurological sequelae), and vaccine development, publishing through peer-reviewed channels and distributing biological samples from its Bio-bank, Brain Bank, and Organoid Bank to external researchers globally.
BPRC's core technology stack combines validated NHP disease models (including proprietary SHIV/SIV hybrid virus models and a macaque Parkinson's model), advanced medical imaging (PET-CT), and complementary animal-free alternatives (organoids, cell cultures, computational models) under the 3R principles (Replacement, Reduction, Refinement). In 2024 the organization conducted 134 animal experiments, down from over 200 in prior years, in pursuit of its stated goal of fewer than 150 experiments per year by 2025. The facility holds AAALAC accreditation and ISO 14001 certification, and is explicitly recognized by the Dutch Cabinet as essential national research infrastructure for pandemic preparedness.
BPRC's revenue model is fundamentally institutional rather than commercial. Funding flows from three sources: (1) core Dutch government grants via the Ministry of Education, Culture and Science (OCW) for national research infrastructure; (2) competitive research grants from international programs including EU Horizon Europe (RABYD-VAX, CAPTIVATE) and CEPI; and (3) philanthropic donations such as the ~£240,000 from the Mercury Phoenix Trust for HIV/AIDS research. BPRC does not sell products or services commercially; instead it disseminates research through scientific publications, biobank sample sharing, and collaborative partnerships with universities (Utrecht, Radboud, Erasmus MC, Amsterdam UMC, LUMC), research institutes (TNO, NKI), and pharmaceutical companies developing vaccines and therapeutics.
Biomedical Primate Research Centre firmographics
Firmographics- Name
- Biomedical Primate Research Centre
- Legal name
- Stichting Biomedical Primate Research Centre
- Website
- https://bprc.nl
- Company type
- Private
- Founded year
- 1997
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- BPRC is a Dutch non-profit research foundation using non-human primate models and biobank resources to advance biomedical research on infectious diseases, neurodegenerative disorders, and vaccine development, serving the global scientific community, pharmaceutical companies, and the Dutch government.
- Ownership category
- akta.pro rank
Biomedical Primate Research Centre industry classification
Industry- Product category
- Preclinical Biomedical Research Services
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Global Health Research, Clinical Trials & Product Development Partnerships (PDPs) (HLAJAOAM)
Keywords
Where Biomedical Primate Research Centre is headquartered
LocationHeadquarters
- HQ city
- Rijswijk
- HQ country
- Netherlands
- HQ region
- Europe
Offices1 record
Markets served
Biomedical Primate Research Centre business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain
Revenue model
- Government Funding: Core funding from Dutch government for pandemic preparedness and biomedical research infrastructure
- Research Grants: Funding from national and international research programs including Horizon Europe, EU H2020 projects (RABYD-VAX, CAPTIVATE), CEPI, and various charitable foundations
- Mercury Phoenix Trust: Approximately 240,000 British pounds donated for HIV/AIDS research through the Freddie Mercury Building partnership
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
Biomedical Primate Research Centre product offering
Product offeringCore offering
BPRC is a non-profit research institute that conducts biomedical research using non-human primate models to study serious infectious diseases (HIV/AIDS, malaria, tuberculosis, COVID-19, influenza) and neurodegenerative disorders (Parkinson's, Alzheimer's). It also develops animal-free alternatives (organoids, cell cultures, computational models), maintains three biobanks (Bio-bank, Brain Bank, Organoid Bank), and provides PET-CT imaging and disease-modeling services to the global research community.
Product overview
Biomedical Primate Research Centre (BPRC) is a research institute providing biomedical research services focused on non-human primate models for serious diseases including infectious diseases (HIV/AIDS, malaria, tuberculosis, corona, influenza) and neurodegenerative diseases (Parkinson's, Alzheimer's). BPRC offers a portfolio of biobanking services including tissue storage (Bio-bank), brain tissue (Brain Bank), and organoid collections. The institute also provides specialized imaging services such as PET-CT scanning for research applications. The research portfolio is organized around three main areas: infectious diseases, neurobiology and aging, and alternative research methods including in vitro technology and genetics.
Differentiator
Problem solved
Functional benefit
Brands
- Freddie Mercury Building: A specialized research building at BPRC opened in 1992, named in memory of Freddie Mercury, dedicated to HIV/AIDS research and funded in partnership with the Mercury Phoenix Trust.
Products and services
- Bio-bank Storage and distribution of tissue and blood samples for medical research. The biobank enables researchers worldwide to study disease mechanisms and test new medicines without additional animal testing.
- Brain Bank Repository of brain tissue samples used for research into brain aging and diseases such as Parkinson's and Alzheimer's. The collection serves as controls for primate studies and reduces animal use.
- Organoid Bank Collection of organoids (miniature organ-like structures grown from stem cells) used for disease research, providing alternatives to animal testing.
- PET-CT Imaging Services Medical imaging technology used for brain research, including Long COVID studies and neurodegenerative disease research such as Parkinson's disease investigations.
Quantifiable outcome
- 134 animal experiments in 2024, reduced from over 200 previously, progressing toward goal of fewer than 150 per year by 2025
- +3 more outcomes
Companies that use Biomedical Primate Research Centre
Customer profileNamed customers3 records
Segments1 record
Ideal customer profiles3 records
Biomedical Primate Research Centre technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Biomedical Primate Research Centre partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered significant, minor and core.
- Mercury Phoenix TrustsignificantThe Mercury Phoenix Trust was established after Freddie Mercury's death to support AIDS research. BPRC's Freddie Mercury Building was named in honor of the Queen singer who died from AIDS in 1991. The trust provided approximately 240,000 British pounds for innovative gene therapy research for HIV/AIDS treatment, demonstrating concrete scientific collaboration between the music industry and biomedical research.
- Queen (Roger Taylor)minorQueen drummer Roger Taylor visited BPRC in 1992 to open the Freddie Mercury Building. The band's support brought worldwide attention to HIV/AIDS research at BPRC and demonstrated how scientific research and public engagement can reinforce each other.
- CEPI (Coalition for Epidemic Preparedness Innovations)coreBPRC participated in the international CEPI congress on preparing for future pandemics. CEPI recognizes that collaboration, scientific expertise, and research infrastructure are essential for rapid development of vaccines and other medical countermeasures.
- RABYD-VAX ConsortiumcoreEU H2020 RABYD-VAX project focused on developing new vaccine technologies. BPRC studies these techniques in primates as part of the consortium, which also produced a massive open online course (MOOC) on vaccinology.
- Dutch Ministry of Education, Culture and Science (OCW)coreThe Dutch government, through Minister Letschert, confirmed the importance of primate research for complex medical questions. BPRC plays a strategic role in national and European research infrastructure for pandemic preparedness and development of new treatments and vaccines.
- BOARD26 Consortium (150+ Dutch Research Institutions)coreMore than 150 scientists from leading Dutch research institutes and universities participated in BOARD26 (Be Open About Animal Research Day), including NKI, Radboud University, Amsterdam UMC, Erasmus MC, Utrecht University, WUR, VU Amsterdam, Maastricht University, Leiden University, UMCG, LUMC, TNO, Netherlands Institute for Neuroscience, and others, to speak about the importance of diverse research methods.
- CAPTIVATE Project ConsortiumcoreEU-funded project for malaria vaccine development. BPRC contributes through primate models for vaccine testing alongside alternative methods using cell cultures developed by the organization.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Biomedical Primate Research Centre competitors and assessment
Company assessmentDirect peers
- German Primate Center (Deutsches Primatenzentrum – DPZ): The DPZ in Göttingen is Europe's largest comparable primate-research center, operating a breeding colony and conducting infectious-disease and neurobiology research with macaques and marmosets, structurally analogous to BPRC and competing for the same EU grants and pharma collaborations.
- Southwest National Primate Research Center (Texas Biomedical Research Institute): NIH-funded NHP center with strong infectious-disease, biodefense, and vaccine-testing programs including BSL-3/4 capabilities — directly comparable to BPRC's pandemic-preparedness positioning.
- Oregon National Primate Research Center (OHSU): NIH-funded NHP research center focused on infectious disease and neuroscience with a large breeding colony; BPRC's macaque Parkinson's model and infectious-disease portfolio map closely to OHSU's specialty areas.
- Tulane National Primate Research Center: NIH-funded NHP research center heavily focused on infectious disease (HIV, TB, malaria) — overlapping closely with BPRC's infectious-disease and vaccine-testing portfolio.
- Yerkes National Primate Research Center (Emory University): One of seven US NIH-funded National Primate Research Centers, operating large breeding colonies and conducting infectious-disease, neuroscience, and vaccine research in NHPs — directly comparable in mission, regulatory standing (AAALAC-accredited), and service offerings to BPRC.
- Wisconsin National Primate Research Center (UW–Madison): NIH-funded NHP center specializing in infectious disease, neurodegenerative models, and developmental biology; comparable breeding-colony and biobanking infrastructure to BPRC.
- California National Primate Research Center (UC Davis): NIH-funded NHP center with programs in infectious-disease, reproductive biology, and neuroscience using macaque models — directly comparable service mix and biobanking/AAALAC-accredited operations to BPRC.
Broad incumbents
- Charles River Laboratories: Global contract-research organization providing NHP research models, bioservices, and preclinical safety assessment — a commercially scaled, broader incumbent in the same downstream market BPRC serves through academic and government channels.
- Institut Pasteur: Established French biomedical-research foundation conducting infectious-disease and neuroscience work — broader in scope than BPRC but overlapping in vaccine-development, primate-model use, and partnerships with global health initiatives (CEPI, WHO).
- CNRS / CEPR (Centre d'Études Primates): French national scientific-research organization operating primate-research facilities and infectious-disease programs; an EU peer in academic/government-funded NHP research that shares BPRC's stakeholder profile.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Biomedical Primate Research Centre social profiles
Digital presenceBiomedical Primate Research Centre compliance and trust
Trust signalCompliance2 records
Biomedical Primate Research Centre financial estimates
Financial estimateRevenue estimate
Valuation estimate
Biomedical Primate Research Centre leadership team
Management profileNumber of profiles
Profiles7 records
Biomedical Primate Research Centre funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Biomedical Primate Research Centre M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Biomedical Primate Research Centre
What does Biomedical Primate Research Centre do?
BPRC is a non-profit research institute that conducts biomedical research using non-human primate models to study serious infectious diseases (HIV/AIDS, malaria, tuberculosis, COVID-19, influenza) and neurodegenerative disorders (Parkinson's, Alzheimer's). It also develops animal-free alternatives (organoids, cell cultures, computational models), maintains three biobanks (Bio-bank, Brain Bank, Organoid Bank), and provides PET-CT imaging and disease-modeling services to the global research community.
Is Biomedical Primate Research Centre a public or private company?
Biomedical Primate Research Centre is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Biomedical Primate Research Centre founded?
Biomedical Primate Research Centre was founded in 1997. It employs 101 to 250 people.
Where is Biomedical Primate Research Centre based?
Biomedical Primate Research Centre is headquartered in Rijswijk, Netherlands, in the Europe region.
How does Biomedical Primate Research Centre make money?
Three revenue lines are on record. Government Funding is the primary driver. The others are research Grants and mercury Phoenix Trust.
Who are Biomedical Primate Research Centre's main competitors?
Direct peers on record are German Primate Center (Deutsches Primatenzentrum – DPZ), Southwest National Primate Research Center (Texas Biomedical Research Institute), Oregon National Primate Research Center (OHSU), Tulane National Primate Research Center, Yerkes National Primate Research Center (Emory University), Wisconsin National Primate Research Center (UW–Madison) and California National Primate Research Center (UC Davis). Broad incumbents are Charles River Laboratories, Institut Pasteur and CNRS / CEPR (Centre d'Études Primates).
Does Biomedical Primate Research Centre have an API?
No public API is recorded for Biomedical Primate Research Centre.
What industry is Biomedical Primate Research Centre in?
Biomedical Primate Research Centre's product category is Preclinical Biomedical Research Services. Its primary akta.pro industry code is HLAJAOAM, Global Health Research, Clinical Trials & Product Development Partnerships (PDPs). Its NAICS code is 5417 and its SIC code is 8731.